Examines in detail the latest developments in theranostics for neuroendocrine tumors and other diseases

Covers a wide spectrum of topics, from radiochemistry to clinical applications

Focuses on gallium-68 but also considers other PET radionuclides

Includes supplementary material: [...]

From the contents: Ge-68/Ga-68 generators.- Automation strategies in Ga-68 radiopharmaceutical preparations.- Post-processing via cation exchange cartridges.- Gallium-68 generator integrated system: elution - purification - concentration integration.- Purification and labelling strategies for 68Ga from 68Ge/68Ga generator eluate.- 67Ga and 68Ga purification studies.- The diversity of [68Ga]Ga-based imaging agents.- Nanoparticles and phage display selected peptides for imaging and therapy of cancer.- "Click" cyclized gallium-68 labeled peptides for molecular imaging and therapy: Synthesis and preliminary in vitro and in vivo evaluation in a melanoma model system.- Early experience with 68Ga-DOTATATE preparation .- 68Ga-radiopharmaceuticals for PET imaging of infection and inflammation.- 68Ga-labeled bombesin analogs for receptor mediated imaging.- A novel 68Ga-labelled pteroic acid-based PET tracer for tumour imaging via the folate receptor.- Measurement of protein synthesis: In vitro comparison of 68Ga-DOTA-puromycin, [3H]tyrosine and 2-fluoro-[3H]tyrosine.- Hypoxia imaging agents labeled with positron emitters.- Lu-177/Y-90 intermediate affinity monoclonal antibodies targeting EGFR and HER2/c-neu: preparation and preclinical evaluation.- Divergent role of 68Ga labeled somatostatin analogs in the work-up of patients with NETs.- Differential uptake of 68Ga-DOTATOC and 68Ga-DOTATATE in PET/CT of gastroenteropancreatic neuroendocrine tumours.